Chemotherapy for colorectal carcinoma: one small step forward, one step backward
N Kemeny
JCO Jun 1 1995: 1287–1290. [PDF]
Who benefits from high-dose therapy for multiple myeloma?
KC Anderson
JCO Jun 1 1995: 1291–1296. [PDF]
	Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer
	M Hill, A Norman, D Cunningham, M Findlay, V Nicolson, A Hill, A Iveson, C Evans, J Joffe, and M Nicolson
	JCO Jun 1 1995: 1297–1302. [Abstract] [PDF]
	Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study
	CG Leichman, TR Fleming, FM Muggia, CM Tangen, B Ardalan, JH Doroshow, FJ Meyers, RF Holcombe, GR Weiss, and A Mangalik
	JCO Jun 1 1995: 1303–1311. [Abstract] [PDF]
	Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma
	G Gahrton, S Tura, P Ljungman, J Blade, L Brandt, M Cavo, T Facon, A Gratwohl, A Hagenbeek, and P Jacobs
	JCO Jun 1 1995: 1312–1322. [Abstract] [PDF]
	Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial
	TR Klumpp, KF Mangan, SL Goldberg, ES Pearlman, and JS Macdonald
	JCO Jun 1 1995: 1323–1327. [Abstract] [PDF]
	Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison
	J Beyer, N Schwella, J Zingsem, I Strohscheer, I Schwaner, H Oettle, S Serke, D Huhn, and W Stieger
	JCO Jun 1 1995: 1328–1335. [Abstract] [PDF]
	Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma
	Y Yan, WC Chan, DD Weisenburger, JR Anderson, MA Bast, JM Vose, PJ Bierman, and JO Armitage
	JCO Jun 1 1995: 1336–1342. [Abstract] [PDF]
	CD30/Ki-1-positive lymphoproliferative disorders of the skin-- clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group
	M Paulli, E Berti, R Rosso, E Boveri, S Kindl, C Klersy, M Lazzarino, G Borroni, F Menestrina, and M Santucci
	JCO Jun 1 1995: 1343–1354. [Abstract] [PDF]
	Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma
	G Nadali, F Vinante, H Stein, G Todeschini, C Tecchio, L Morosato, M Chilosi, F Menestrina, MC Kinney, and JP Greer
	JCO Jun 1 1995: 1355–1360. [Abstract] [PDF]
	Testicular lymphoma: late relapses and poor outcome despite doxorubicin- based therapy
	N Touroutoglou, MA Dimopoulos, A Younes, M Hess, W Pugh, J Cox, F Cabanillas, and AH Sarris
	JCO Jun 1 1995: 1361–1367. [Abstract] [PDF]
	Comparison of treatment regimens for pediatric lymphoblastic non- Hodgkin's lymphoma: a Childrens Cancer Group study
	DG Tubergen, MD Krailo, AT Meadows, J Rosenstock, M Kadin, M Morse, D King, PG Steinherz, and JH Kersey
	JCO Jun 1 1995: 1368–1376. [Abstract] [PDF]
	Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group
	RI Jakacki, PM Zeltzer, JM Boyett, AL Albright, JC Allen, JR Geyer, LB Rorke, P Stanley, KR Stevens, and J Wisoff
	JCO Jun 1 1995: 1377–1383. [Abstract] [PDF]
	Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC
	AS Sarkis, DF Bajorin, VE Reuter, HW Herr, G Netto, ZF Zhang, PK Schultz, C Cordon-Cardo, and HI Scher
	JCO Jun 1 1995: 1384–1390. [Abstract] [PDF]
	Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy
	JM Timmerman, DW Northfelt, and EJ Small
	JCO Jun 1 1995: 1391–1397. [Abstract] [PDF]
	N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer
	LJ Brandes, SP Bracken, and EW Ramsey
	JCO Jun 1 1995: 1398–1403. [Abstract] [PDF]
	Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow- up of a prospective randomized trial
	HW Herr, DM Schwalb, ZF Zhang, PC Sogani, WR Fair, WF Whitmore, Jr, and HF Oettgen
	JCO Jun 1 1995: 1404–1408. [Abstract] [PDF]
	Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer
	BD Minsky, JA Conti, Y Huang, and K Knopf
	JCO Jun 1 1995: 1409–1416. [Abstract] [PDF]
	Tumor proliferation in rectal cancer following preoperative irradiation
	CG Willett, G Warland, MP Hagan, WJ Daly, J Coen, PC Shellito, and CC Compton
	JCO Jun 1 1995: 1417–1424. [Abstract] [PDF]
	Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol
	C Blanke, R Ansari, R Mantravadi, R Gonin, R Tokars, W Fisher, K Pennington, T O'Connor, S Rynard, and M Miller
	JCO Jun 1 1995: 1425–1429. [Abstract] [PDF]
	Phase II study of paclitaxel in patients with extensive-disease small- cell lung cancer: an Eastern Cooperative Oncology Group study
	DS Ettinger, DM Finkelstein, RP Sarma, and DH Johnson
	JCO Jun 1 1995: 1430–1435. [Abstract] [PDF]
	Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer
	JD Hainsworth, N Levitan, GL Wampler, CP Belani, MS Seyedsadr, J Randolph, LP Schacter, and FA Greco
	JCO Jun 1 1995: 1436–1442. [Abstract] [PDF]
	Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281
	J Aisner, C Cirrincione, M Perloff, M Perry, D Budman, J Abrams, L Panasci, H Muss, M Citron, and J Holland
	JCO Jun 1 1995: 1443–1452. [Abstract] [PDF]
	Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study
	G Falkson, C Holcroft, RS Gelman, DC Tormey, JM Wolter, and FJ Cummings
	JCO Jun 1 1995: 1453–1458. [Abstract] [PDF]
	Appropriateness of adjuvant systemic therapy for axillary node-negative breast cancer: a physician opinion survey
	CA Sawka, AM O'Connor, HA Llewellyn-Thomas, T To, SP Pinfold, and D Harrison- Woermke
	JCO Jun 1 1995: 1459–1469. [Abstract] [PDF]
	Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
	T Jansson, JE Westlin, H Ahlstrom, A Lilja, B Langstrom, and J Bergh
	JCO Jun 1 1995: 1470–1477. [Abstract] [PDF]
	Restrictive lung disease following treatment for malignant brain tumors: a potential late effect of craniospinal irradiation
	RI Jakacki, CM Schramm, BR Donahue, F Haas, and JC Allen
	JCO Jun 1 1995: 1478–1485. [Abstract] [PDF]
	Phase II study of continuous infusion fluorouracil and interferon alfa- 2b in the palliation of malignant neuroendocrine tumors
	HJ Andreyev, P Scott-Mackie, D Cunningham, V Nicolson, AR Norman, SS Badve, A Iveson, and MC Nicolson
	JCO Jun 1 1995: 1486–1492. [Abstract] [PDF]
	Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer
	L De Andres, J Brunet, A Lopez-Pousa, J Burgues, M Vega, JM Tabernero, R Mesia, and JJ Lopez
	JCO Jun 1 1995: 1493–1500. [Abstract] [PDF]
	Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors
	JS Lee, RA Newman, SM Lippman, FV Fossella, M Calayag, MN Raber, IH Krakoff, and WK Hong
	JCO Jun 1 1995: 1501–1508. [Abstract] [PDF]
	Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients
	M Sanders and W Zuurmond
	JCO Jun 1 1995: 1509–1512. [Abstract] [PDF]
	Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients
	EB Rubenstein, A Fender, KV Rolston, LS Elting, P Prasco, J Palmer, I Road, RE Pollock, S Frisbee-Hume, and D Laurence
	JCO Jun 1 1995: 1513–1519. [Abstract] [PDF]
	Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation
	E Bruera, R Fainsinger, K Spachynski, N Babul, Z Harsanyi, and AC Darke
	JCO Jun 1 1995: 1520–1527. [Abstract] [PDF]
Retrieval therapy for isolated CNS relapse in childhood acute lymphoblastic leukemia
GK Rivera, RC Ribeiro, and CH Pui
JCO Jun 1 1995: 1528–1529. [PDF]
Placebo-controlled randomized study of hydrazine sulfate in lung cancer
MP Kosty, JE Herndon, 2nd, MR Green, and OR McIntyre
JCO Jun 1 1995: 1529–1530. [PDF]
Treatment of stage I Wilms' tumor
DM Green
JCO Jun 1 1995: 1530. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.